Regulatory FDA Expands AI Capabilities and Completes Data Platform Consolidation FDAFDA announced major steps in its bold initiative to modernize the agency.Read full story pharminent May 6, 2026 (Last updated: May 7, 2026) FDA FDA announced major steps in its bold initiative to modernize the agency. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipelineNext: Halozyme and Oruka sign agreement for Hypercon technology Related Stories Regulatory FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients pharminent June 2, 2026 Regulatory FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy pharminent June 1, 2026 Regulatory Replimune gives cancer immunotherapy a third try after FDA leadership shakeup pharminent May 29, 2026
